Jump to main content
Jump to site search

Issue 20, 2021

Inhibition of thrombin activity by a covalent-binding aptamer and reversal by the complementary strand antidote

Author affiliations

Abstract

Alleviating the potential risk of irreversible adverse drug effects has been an important and challenging issue for the development of covalent drugs. Here we created a DNA-aptamer-type covalent drug by introducing a sulfonyl fluoride warhead at appropriate positions of the thrombin binding aptamer to create weaponized covalent drugs. We showed the de-activation of thrombin by the novel modality, followed by its re-activation by the complementary strand antidote at an arbitrary time. We envision that such on-demand reversal of covalent drugs will alleviate the major concern of potentially irreversible ADEs and accelerate the translational application of covalent aptamer drugs.

Graphical abstract: Inhibition of thrombin activity by a covalent-binding aptamer and reversal by the complementary strand antidote

Supplementary files

Article information


Submitted
14 Dec 2020
Accepted
10 Feb 2021
First published
15 Feb 2021

Chem. Commun., 2021,57, 2483-2486
Article type
Communication

Inhibition of thrombin activity by a covalent-binding aptamer and reversal by the complementary strand antidote

Y. Tabuchi, J. Yang and M. Taki, Chem. Commun., 2021, 57, 2483 DOI: 10.1039/D0CC08109D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.


Social activity

Search articles by author

Spotlight

Advertisements